We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-17.83%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$404B
AUM Growth
-$174B
Cap. Flow
-$8.47B
Cap. Flow %
-2.09%
Top 10 Hldgs %
31.86%
Holding
14,668
New
1,801
Increased
4,898
Reduced
5,771
Closed
1,897

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$824M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$459M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$301M
4
WBD icon
Warner Bros
WBD
+$287M
5
TSLA icon
Tesla
TSLA
+$230M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.22%
2 Technology 1.79%
3 Consumer Discretionary 1.52%
4 Communication Services 1.04%
5 Financials 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LHDX
11876
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$53K ﹤0.01%
28,521
-38,871
-58% -$94.5K
HITI
11877
High Tide
HITI
$226M
$52K ﹤0.01%
25,675
+10,162
+66% +$30.1K
OPRA
11878
Opera Ltd
OPRA
$1.73B
$52K ﹤0.01%
11,900
+1,780
+18% +$9.38K
VATE icon
11879
CALL
INNOVATE Corp
VATE
$106M
$52K ﹤0.01%
2,980
-4,130
-58% -$113K
ONCR
11880
DELISTED
Oncorus, Inc.
ONCR
$52K ﹤0.01%
+41,192
New +$56K
ILLM
11881
PUT
DELISTED
illumin Holdings Inc. Common Shares
ILLM
$52K ﹤0.01%
22,600
-300
-1% -$808
AMTX icon
11882
Aemetis
AMTX
$135M
$51K ﹤0.01%
10,441
-34,638
-77% -$303K
BKKT.WS icon
11883
Bakkt Inc Warrants
BKKT.WS
$239K
$51K ﹤0.01%
78,121
+12,739
+19% +$14.5K
CGEN icon
11884
CALL
Compugen
CGEN
$261M
$51K ﹤0.01%
27,400
-34,600
-56% -$74.7K
HEPA
11885
CALL
DELISTED
Hepion Pharmaceuticals
HEPA
$51K ﹤0.01%
89
-128
-59% -$107K
HRTX icon
11886
CALL
Heron Therapeutics
HRTX
$63M
$51K ﹤0.01%
18,200
-83,900
-82% -$337K
VTSI icon
11887
VirTra
VTSI
$34.8M
$51K ﹤0.01%
10,400
-43,618
-81% -$222K
WVE icon
11888
CALL
Wave Life Sciences
WVE
$1.02B
$51K ﹤0.01%
15,600
+5,000
+47% +$9.62K
GPUS
11889
PUT
Hyperscale Data Inc
GPUS
$30.7M
-1
Closed -$310K
MTVA
11890
MetaVia Inc
MTVA
$10.9M
$51K ﹤0.01%
+41
New +$64.7K
ENSV
11891
CALL
DELISTED
Enservco Corp.
ENSV
$51K ﹤0.01%
+26,100
New +$64.9K
SURF
11892
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$51K ﹤0.01%
31,046
-2,319
-7% -$4.82K
ALAR
11893
Alarum Technologies
ALAR
$12.1M
$50K ﹤0.01%
+10,255
New +$60.2K
BDSX icon
11894
CALL
Biodesix
BDSX
$300M
$50K ﹤0.01%
+1,520
New +$49.4K
RJET
11895
PUT
Republic Airways Holdings
RJET
$861M
$50K ﹤0.01%
1,533
-5,947
-80% -$280K
RYAM icon
11896
PUT
Rayonier Advanced Materials
RYAM
$570M
$50K ﹤0.01%
18,900
-13,300
-41% -$59.6K
SACH
11897
PUT
Sachem Capital Corp
SACH
$43.2M
$50K ﹤0.01%
+12,300
New +$57.8K
TK icon
11898
PUT
Teekay
TK
$1.12B
$50K ﹤0.01%
17,500
+5,300
+43% +$17.3K
PVLA
11899
CALL
Palvella Therapeutics
PVLA
$2.17B
$50K ﹤0.01%
338
-372
-52% -$67.9K
PGRU
11900
PUT
DELISTED
PropertyGuru Group Limited
PGRU
$50K ﹤0.01%
+11,100
New +$70.3K

Similar funds

Jeff Yass's Q2 2022 Portfolio in Review

As of Q2 2022, Jeff Yass held 14,668 positions worth $404B, down 30% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q2 2022 filing shows 1,801 new, 4,898 increased, 5,771 reduced and 1,897 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.88B.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 92% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q2 2022 buy was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M.
  • Jeff Yass added most to Amazon in Q2 2022, an estimated $824M increase.
  • Jeff Yass's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.88B.
  • Jeff Yass fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $176M.
  • Jeff Yass's ten largest holdings make up 32% of its $404B portfolio in Q2 2022.
  • Jeff Yass opened 1,801 new positions and closed 1,897 in Q2 2022.
  • Jeff Yass's portfolio value fell 30% quarter-over-quarter to $404B.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.